EUVIMEDEUVIMED entdecken
Crossref

Synovial Anti Cyclic Citrullinated Peptide Antibodies in Comparison with Serum Antibodies in Early and Late Rheumatoid Arthritis

Kamila Hashemzadeh, Massoud Saghafi, Mohammad Khajedaluee, Maryam Sahebari

Fortune Journal of Rheumatology · 2020

DOI: 10.26502/fjr.26880019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fortune Journal of Rheumatology, 2020. Verfasst von Kamila Hashemzadeh und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The study objective was to evaluate the diagnostic value of synovial fluid anti cyclic citrullinated peptide (sf-anti CCP) in comparison to serum anti CCP (s-anti CCP) in early and late rheumatoid arthritis and to clarify its correlation with disease activity.

Methods

In this cross-sectional study a total of 45 patients aged between 18 and 70 years with rheumatoid arthritis (RA) according to the ACR criteria were enrolled. Twenty six patients had a disease duration of more than 2 years (late RA) whereas 19 cases were referred to as early RA (

Zitieren

APA

Hashemzadeh, K., Saghafi, M., Khajedaluee, M., & Sahebari, M. (2020). Synovial Anti Cyclic Citrullinated Peptide Antibodies in Comparison with Serum Antibodies in Early and Late Rheumatoid Arthritis. Fortune Journal of Rheumatology. https://doi.org/10.26502/fjr.26880019

Vancouver

Hashemzadeh K, Saghafi M, Khajedaluee M, Sahebari M. Synovial Anti Cyclic Citrullinated Peptide Antibodies in Comparison with Serum Antibodies in Early and Late Rheumatoid Arthritis. Fortune Journal of Rheumatology. 2020. doi:10.26502/fjr.26880019

BibTeX
@article{Hashemzadeh2020,
  author = {Hashemzadeh, Kamila and Saghafi, Massoud and Khajedaluee, Mohammad and Sahebari, Maryam},
  title = {Synovial Anti Cyclic Citrullinated Peptide Antibodies in Comparison with Serum Antibodies in Early and Late Rheumatoid Arthritis},
  journal = {Fortune Journal of Rheumatology},
  year = {2020},
  doi = {10.26502/fjr.26880019}
}
Kostenlos starten →